Table 2.

Effect of H₂O₂ decontamination methods on viruses and microorganisms

References	Media	Method and dose	Phase times (min)	Organism	Effectiveness (log reduction)
6	3M 1860, 1870, 1804 and AO 1054 FFRs (N = 1)	VHP™ (Steris ARD) 5 g/min then 2.2 g/min	Gas 3; Dwell 30 >750 ppm	VSV SARS-CoV-2	≥6
7	3M 1860S FFR pieces inoculated	VHP (Steris ARD) 410 ppm	180	SARS-CoV-2	≥5
8	AO N9504C FFR pieces inoculated	VHP 1000 ppm	10	SARS-CoV-2	≥6
6	3M 1860, 1870, 1804, and AO 1054 FFRs	HPGP (STERRAD 100NX)	47	VSV	≥6
12	3M 1860 N95 FFR inoculated with droplets or aerosol	HPV (Bioquell) 2 g/min then 0.5 g/min	Inject 20; Dwell 150	Geobacillus stearothermophilus spores	≥6
13	3M 1870 inoculated (N = 3 for each phage)	HPV (Bioquell) 16 g/min	Inject 30–40; Dwell 25	Phage phi-6 Phage T7 Phage T1	≥6
14	3M 1860 pieces inoculated	HPV (Bioquell) 16 g/min 446–495 ppm	Dwell 20	Phage (MS2, Phi6) Influenza MHV Escherichia coli Staphylococcus aureus Aspergillus niger G. stearothermophilus spores	≥2–5
15	3M 1860, 1870+, 8511, 9211, HW N11125 FFRs inoculated	Curis	Inject 12; Dwell 50	Herpes Simplex Virus 1 Coxsackievirus B3 Phage phi6	≥6

FFR, filtering facepiece respirator; HPGP, hydrogen peroxide gas plasma; MHV, mouse hepatitis virus; VSV, vesicular stomatitis virus.